Real-Life Outcomes of First-Line Palliative Chemoimmunotherapy in Oesophago-Gastric Cancers: A Multi-Centre Retrospective Cohort Study https://t.co/dBS0FQC0Nh @VelindreCS
Interhospital variations in practice and technical outcomes for endoscopic resection of early oesophagogastric adenocarcinoma: multicentre CONGRESS data set analysis @VelindreCS https://t.co/bkhdHHN8Ky
Prevention & management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) & Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement https://t.co/gEqYWQfUDF
Treatment and outcomes of immunotherapy related colitis and hepatitis- a multi-centre cohort study in the United Kingdom by the National Oncology Trainee Collaborative for Healthcare Research (NOTCH) https://t.co/vsdSg5Qlmv
Intraperitoneal and Intravenous Paclitaxel Plus S-1 for Gastric Cancer With Peritoneal Metastasis: A Phase 3 Randomized Clinical Trial https://t.co/TYErvNZBI9
Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review https://t.co/n9VBIEdrXx
LAPIS: A Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Neoadjuvant Pamrevlumab With Chemotherapy for Patients With Locally Advanced Pancreatic Cancer https://t.co/3iMxIL9aiF
Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma https://t.co/UfyfLINfHQ
Real-world obesity prevalence and history in 79 271 patients receiving systemic anticancer therapy across 13 cancer types in England (2013-2023) https://t.co/zZ7ysaTiRT
Global prevalence of FGFR2b protein overexpression in advanced gastric cancer and gastroesophageal junction cancers: pooled analysis of two bemarituzumab phase III studies https://t.co/pQYUbwfhSn #Cancer